A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris

NCT01016977 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Clindamycin 1%/Benzoyl Peroxide 5% and 0.1% tazarotene
DRUG: clindamycin phosphate 1.2%/benzoyl peroxide 2.5% and 0.1% tazarotene

Sponsor

Stiefel, a GSK Company

Collaborators

[object Object]